This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

News
3 Nov 2020

Pill Connect secures £0.5m to take electronic smart pill bottle to commercial launch

Device provides clinicians and trialists with comprehensive data on a patient's adherence pattern.

Pill Connect, formerly known as Elucid mHealth, has secured £510,000 funding to complete development of the design, electronics and software for submission to the regulatory authorities in both Europe and the US and continue through to commercial launch.

Pill Connect was developed to prompt patients to take their medications on time and to send a report back to the doctor to advise them of their patients' adherence record. The prompt comes from an app on their mobile phone which when acknowledged dispenses a pill or capsule from the bottle through the dispensing cap. Should the patient not wish to take their medication due to illness or an adverse reaction they can respond through the app.

In addition to providing a detailed adherence record, the Pill Connect system allows for an immediate intervention by an automated notification or phone call should the app not be activated.

This is particularly important in clinical trials where poor adherence can compromise the validity of the trial. It is well known that compliance rapidly declines over time and in longer studies, especially lasting longer than 9 months, adherence drops off. The Pill Connect system allows monitors to not only know when that happens but to have the opportunity to intervene and talk to the person in real time, to assess what can be done to help them become more compliant.

The monitor has access to a complete dashboard covering the whole trial so that everyone involved can be advised in real time of the rate of compliance or issues which affect adherence.

The Pill Connect system has already undergone several successful placebo trials which have proven the robustness of the system, the ability to influence better compliance in real time and frictionless patient acceptance.

The system continues to be trialled by both clinical research organizations and major pharma companies who have found that the ability of the system to interact in real time differentiates it from many other products in development.

The Pill Connect dispenser mechanism and electronics are designed to fit as a cap onto a standard pill bottle. The capacity of the pill bottle will depend upon the pill size but will have a minimum of 30 pills. The dispensing mechanism can be adjusted to handle pills or capsules of different sizes.

Related News